Our Team.

Anne has PhDs in Signal Processing and Molecular Biology. Prior to Prothea she worked as a programme manager for BAE Systems, and then at the University of Edinburgh, where she managed a portfolio of translational healthcare projects.

Annya has a PhD in Molecular Imaging and is Head of Clinical Operations at Prothea Technologies. Annya has a background in clinical trial design and delivery, regulatory frameworks and compliance, data management systems and ensuring on-time and on-budget study outcomes. At Prothea, Annya leads the strategic design and execution of clinical validation programmes focused on lung disease, generating high-quality, endpoint-driven evidence to support regulatory approval and clinical adoption.

Caitlin qualified with a BEng(Hons) in Mechanical Engineering from Curtin University, Perth, Australia; and a MSc in Biomedical Engineering from the Technische Hochschule and University of Lübeck. With subsequent experience in medical device development and biotech manufacturing, Caitlin specializes at Prothea in manufacturing scale-up and process development.

Charlotte has a background in physics, with PhD in quantum optics. As head of fibre engineering she is responsible for the transfer of technology from research and development through to manufacturing.

Crispin was Smith & Nephew’s Group Strategy Director and President of its Endoscopy Division in the US; and then led the team that delivered $400m of exits at Biocompatibles plc. Prior to Prothea, Crispin served as the UK Trade Commissioner for South Asia, based in Mumbai, India.

Fabian has a PhD in Accelerator Physics and more than 10 years in the medical technology industry – latterly leading proton therapy R&D at Varian. Fabian leads Prothea’s Manufacturing activities from the Cologne site.

Gareth is Vice President of research and development at Prothea. He is a specialist in optical instrumentation with a PhD in chemical physics and a background of producing novel optical sensing and imaging instrumentation. He is leading Prothea’s research and development for their next generation fluorescence imaging and treatment platforms.

Harry is head of fine tool research and development at Prothea. He has a PhD in the physics of optical waveguides for medicine and 7 years experience designing minimally invasive diagnostic and therapeutic tools.

Hazel has a PhD in Optical Medical Imaging and has several years’ experience utilising fluorescence lifetime for various applications, including studying differences between healthy and cancerous cells and building fluorescence lifetime imaging systems. Hazel leads on the testing and technical documentation for various medical devices for Prothea.

Hilola has an MSc in Neuroscience and a BSc in Bio & Brain Engineering and has held quality and regulatory posts at Class III and IIb medical device manufacturers, guiding certifications across Europe and Asia.  Hilola steers our product‑lifecycle processes, aligning manufacturing readiness and regulatory strategy.

Jim is the Chief Technical Officer. He has a research background leading the development of new optical fibres for use in medical technology. He has run research programmes in academia and industry. His role is to have technical oversight of the project.

Joel is Head of Software. He has a PhD in physics and a background in developing software for data acquisition systems and medical data processing. His role is to develop the core data acquisition software and its integration with real-time AI-driven data analysis.

Chair of Molecular Imaging & Healthcare Technology and Consultant Physician in Respiratory Medicine at the University of Edinburgh, Scotland, UK. Kev’s academic group investigates disruptive technologies to advance Respiratory Medicine and Critical Care. Kev is a Director of Prothea Technologies and Chief Scientific and Medical Officer.

Mazi brings more than 35 years of business experience with a background in investment banking and recent leadership roles in two other deep-tech spinoffs.  Mazi earned his BA from UC Berkeley, and holds an MBA and MSc from the Universities of Chicago and Oxford respectively.   Mazi is based in the Bay area and leads Prothea’s activities in the US.

Morag’s background is in Operations & Office Management as well as Intranet Design, Content Management and Print Production Management. At Prothea Technologies Morag provides Executive Support to the COO and CEO, Business Development, Marketing, Office Management, Conference Planning and Business Operations.

Qiang holds a PhD from the University of Leeds (2017) in signal and image processing for electrical tomography and then moved to biomedical imaging at the University of Edinburgh (2018). With over 15 years of experience in signal and image processing and software engineering, he brings deep technical expertise to developing innovative healthcare technologies.

Vikki is head of regulatory and quality affairs. She has a background in clinical trials and establishing Quality Management Systems. This role is to ensure that the project is carried out within the framework of medical device regulation and that the algorithms and associated software are developed and documented with appropriate consideration of design control, traceability and risk assessment.

Ahsan Akram is  a Clinician Scientist and Fellow at the University of Edinburgh and Honorary Consultant in Respiratory Medicine in NHS Lothian.  Having completed a PhD in Optical Imaging, he conducted research in stromal biology in NSCLC supported by Cancer Research UK.  Now under Ahsan’s UKRI fellowship, his group researches the tumour microenvironment to understand how different cells shape tumour progression and patient outcome. Ahsan is a consultant to the Company.